Lexagene Holdings (TSXV:LXG.H) Accounts Payable & Accrued Expense : C$0.62 Mil (As of Nov. 2022)

View and export this data going back to 2007. Start your Free Trial

What is Lexagene Holdings Accounts Payable & Accrued Expense?

Lexagene Holdings's quarterly accounts payable & accrued expense increased from May. 2022 (C$0.72 Mil) to Aug. 2022 (C$0.83 Mil) but then declined from Aug. 2022 (C$0.83 Mil) to Nov. 2022 (C$0.62 Mil).

Lexagene Holdings's annual accounts payable & accrued expense increased from Feb. 2020 (C$0.29 Mil) to Feb. 2021 (C$0.91 Mil) but then declined from Feb. 2021 (C$0.91 Mil) to Feb. 2022 (C$0.73 Mil).

Lexagene Holdings Accounts Payable & Accrued Expense Historical Data

The historical data trend for Lexagene Holdings's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Accounts Payable & Accrued Expense Chart

Lexagene Holdings Annual Data

Trend

Mar13

Mar14

Mar15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.32

0.42

0.29

0.91

0.73

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															0.43	0.73	0.72	0.83	0.62

Lexagene Holdings Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Lexagene Holdings (TSXV:LXG.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (TSXV:LXG.H) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915

Website

https://www.lexagene.com

Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.

Lexagene Holdings (TSXV:LXG.H) Headlines

No Headlines